| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |